<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Sangamo Therapeutics — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/sangamo-therapeutics</link>
    <description>Plain-English explanations of patents assigned to Sangamo Therapeutics, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Sat, 12 Sep 2026 23:41:09 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/sangamo-therapeutics/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>How Engineered TALE Proteins Can Edit Genes</title>
      <link>https://patentbrief.org/patent/us/11661612/dna-binding-proteins-and-uses-thereof</link>
      <description>This patent describes engineered DNA-binding proteins called TALEs, which are shortened and modified to precisely target and edit specific DNA sequences in cells, potentially for gene therapy.</description>
      <pubDate>Tue, 30 May 2023 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/11661612/dna-binding-proteins-and-uses-thereof</guid>
    </item>
  </channel>
</rss>
